After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
CytomX Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of CytomX Therapeutics Inc is $53.34M. A total of 0.69 million shares were traded on the day, compared to an average of 1.88M shares.
In the most recent transaction, McCarthy Sean A. sold 37,656 shares of CTMX for 0.60 per share on Mar 18 ’25. After the transaction, the CEO now owns 995,195 company shares. In a previous transaction on Mar 18 ’25, Ogden Christopher sold 8,551 shares at 0.60 per share. CTMX shares that Chief Financial Officer owns now total 201,026.
Among the insiders who sold shares, Chu Yu-Waye disposed of 4,025 shares on Mar 18 ’25 at a per-share price of $0.60. This resulted in the Chief Medical Officer holding 135,725 shares of CTMX after the transaction. In another insider transaction, ROWLAND LLOYD A sold 10,203 shares at $0.60 per share on Mar 18 ’25. Company shares held by the General Counsel now total 120,594.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CTMX has a high of $5.85 and a low of $0.56.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CTMX’s latest balance sheet shows that the firm has $305.23M in Cash & Short Term Investments as of fiscal 2021. There were $21.67M in debt and $77.87M in liabilities at the time. Its Book Value Per Share was -$0.01, while its Total Shareholder’s Equity was -$459.00k.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTMX is Buy with a score of 4.14.
